Literature DB >> 3190538

Assessment of visual function in patients with age-related macular degeneration and low visual acuity.

M F Alexander1, M G Maguire, T M Lietman, J R Snyder, M J Elman, S L Fine.   

Abstract

The visual function of 100 eyes with low visual acuity of 100 patients with age-related macular degeneration was examined using measurements of visual acuity, peak contrast sensitivity, and the ability to read, to tell time, and to distinguish colors, products, and facial expressions. Visual acuity and peak contrast sensitivity were correlated (r = .62); however, a range of peak contrast sensitivities was observed at each level of acuity. When considered individually, visual acuity and peak contrast sensitivity were related to the ability to perform each of the tasks. When multivariate methods were applied, both visual acuity and peak contrast sensitivity contributed independently to the ability to read and tell time. Among patients with the same contrast sensitivity, visual acuity had little or no relationship to the ability to identify colors, products, and faces.

Entities:  

Mesh:

Year:  1988        PMID: 3190538     DOI: 10.1001/archopht.1988.01060140711040

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  23 in total

1.  Is cataract surgery justified in patients with age related macular degeneration? A visual function and quality of life assessment.

Authors:  A M Armbrecht; C Findlay; S Kaushal; P Aspinall; A R Hill; B Dhillon
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

2.  Face recognition in age related macular degeneration: perceived disability, measured disability, and performance with a bioptic device.

Authors:  L Tejeria; R A Harper; P H Artes; C M Dickinson
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

3.  Improvement in near visual function after macular translocation surgery with 360-degree peripheral retinectomy.

Authors:  Cynthia A Toth; Deborah J Lapolice; Avie D Banks; Sandra S Stinnett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-05       Impact factor: 3.117

Review 4.  Emerging roles for nuclear receptors in the pathogenesis of age-related macular degeneration.

Authors:  Goldis Malek; Eleonora M Lad
Journal:  Cell Mol Life Sci       Date:  2014-08-26       Impact factor: 9.261

5.  Macular degeneration: do conventional measurements of impaired visual function equate with visual disability?

Authors:  M E McClure; P M Hart; A J Jackson; M R Stevenson; U Chakravarthy
Journal:  Br J Ophthalmol       Date:  2000-03       Impact factor: 4.638

6.  A standardized obstacle course for assessment of visual function in ultra low vision and artificial vision.

Authors:  Amy Catherine Nau; Christine Pintar; Christopher Fisher; Jong-Hyeon Jeong; KwonHo Jeong
Journal:  J Vis Exp       Date:  2014-02-11       Impact factor: 1.355

7.  A vision specific functional index for use in patients with age related macular degeneration.

Authors:  P M Hart; U Chakravarthy; M R Stevenson; J Q Jamison
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

8.  Differences in reading performance of patients with Drusen maculopathy and subretinal fibrosis after CNV.

Authors:  Sibylla Richter-Mueksch; Michael Stur; Eva Stifter; Wolfgang Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-27       Impact factor: 3.117

9.  Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment.

Authors:  Michael E Ward; Jeffrey M Gelfand; Li-Yung Lui; Yvonne Ou; Ari J Green; Katie Stone; Kathryn L Pedula; Steven R Cummings; Kristine Yaffe
Journal:  Ann Neurol       Date:  2018-04-11       Impact factor: 10.422

10.  Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. A multicenter, prospective 1-year study.

Authors:  Livio Garattini; Emanuela Castelnuovo; Paolo Lanzetta; Cecilia Viscarra; Elena Ricci; Fabio Parazzini
Journal:  Eur J Health Econ       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.